M
Mycophyto
An innovative know-how concerning the implementation of natural synergies between plants and soil micro-organisms
About Mycophyto
Mycophyto is a French biotechnology company specializing in the research and development of solutions for regenerative agriculture. The company focuses on the use of arbuscular mycorrhizal fungi (AMF) to improve soil health and crop performance.
Read full description
Mycophyto has developed a patented technology for the large-scale production of mycorrhizal fungi. This technology allows the company to offer customized solutions to farmers, based on the specific needs of their soils and crops. The company's business model is based on the sale of these customized fungal inoculants to agricultural producers. Mycophyto's clients include farmers, winegrowers, and other agricultural professionals looking to improve the sustainability and profitability of their operations.
The company operates in the agricultural biotechnology market, with a focus on sustainable and regenerative farming practices. By harnessing the symbiotic relationship between plants and mycorrhizal fungi, Mycophyto aims to reduce the need for chemical fertilizers and pesticides, while improving water use efficiency and crop resilience.
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Grasse, France
- Employees
- 43
- Open positions
- 2
- Dealroom signal
- 65.0/100
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Spinout, Sustainable Development Goals, Biotechnology in Food, Climate Tech, Agritech and Foodtech, Observatoire Deeptech, Greentech, Woman Founder
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2026 | $18M | $70M | Crédit Agricole · Noshaq · Bpifrance · BNP Paribas | ↗ |
| GRANT✓Other financing | Dec 2024 | $2.2M | — | French Government | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Mycophyto is 150 monthly website visits, down 96.3% over the last three months. Mycophyto's team declined 2.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
- OIOlbia Invest
Région Sud Investissement
EY
Crédit Agricole
French Government
Series A7 investors entered at this stage
CIC
Bpifrance
Caisse d'Epargne
BNP Paribas
Innovacom
Noshaq
CDG Invest
Other known investors9 additional known investors
HEC Paris
CDL-Paris
CNRS Innovation
French National Centre for Scientific Research - CNRS
HEC Paris Incubator
INRAE
HECTAR Accelerator
Paris Business Angels
Turenne Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mycophyto on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mycophyto’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.